RUA Life Sciences (LON:RUA) Stock Price Up 2.7% – Should You Buy?

RUA Life Sciences plc (LON:RUA)’s share price rose 2.7% during trading on Tuesday . The company traded as high as GBX 24 and last traded at GBX 24. 4,531 shares changed hands during mid-day trading, a decline of 98% from the average session volume of 233,580 shares. The stock had previously closed at GBX 23.36.

RUA Life Sciences Stock Performance

The firm’s 50-day moving average is GBX 21.03 and its 200 day moving average is GBX 17.71. The stock has a market cap of £15.43 million, a PE ratio of -2.61 and a beta of 0.95. The company has a debt-to-equity ratio of 18.95, a quick ratio of 7.32 and a current ratio of 4.64.

RUA Life Sciences (LON:RUA) last issued its quarterly earnings results on Tuesday, June 30th. The company reported GBX (0.33) earnings per share for the quarter. RUA Life Sciences had a negative return on equity of 2.03% and a negative net margin of 3.26%.

About RUA Life Sciences

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.